Dette skal følge CPMP Guideline for Risk Management Systems for Medicinal Products for Human Use and skal indsendes inden 30 dage efter Commission Decision.
This should be in line with the CHMP Guideline on Risk Management Systems for Medicinal Products for Human use and should be submitted within 30 days after the Commission Decision.